Variant report
Variant | nsv900832 |
---|---|
Chromosome Location | chr13:89481804-89545643 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:89528545..89531167-chr13:91999570..92001170,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000215417 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563738383 | chr13:89502611-89502612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187242617 | chr13:89502642-89502643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368482980 | chr13:89502721-89502722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs541485346 | chr13:89502770-89502771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs543299292 | chr13:89502773-89502774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs3864987 | chr13:89502819-89502820 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs191674006 | chr13:89502831-89502832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540872290 | chr13:89502865-89502866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554940094 | chr13:89502879-89502880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77726900 | chr13:89502917-89502918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527780541 | chr13:89502943-89502944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552731951 | chr13:89502954-89502955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570843023 | chr13:89503035-89503036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184797348 | chr13:89503065-89503066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9588517 | chr13:89503076-89503077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572032414 | chr13:89503083-89503084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369281633 | chr13:89503148-89503149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550465902 | chr13:89503169-89503170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs2808807 | chr13:89503188-89503189 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs187706656 | chr13:89503240-89503241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563936719 | chr13:89503247-89503248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558097831 | chr13:89503260-89503261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192681612 | chr13:89503298-89503299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2808808 | chr13:89503307-89503308 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs539140623 | chr13:89503319-89503320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557467529 | chr13:89503336-89503337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7139923 | chr13:89503353-89503354 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs140130695 | chr13:89503368-89503369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs74580150 | chr13:89503399-89503400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201435886 | chr13:89513839-89513840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548076034 | chr13:89513876-89513877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs117527582 | chr13:89513929-89513930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2807222 | chr13:89513962-89513963 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs546702850 | chr13:89513974-89513975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs147457719 | chr13:89514011-89514012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538658953 | chr13:89514028-89514029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536662698 | chr13:89514054-89514055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557591062 | chr13:89514106-89514107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575838514 | chr13:89514134-89514135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139945575 | chr13:89514146-89514147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs555181334 | chr13:89514171-89514172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143923370 | chr13:89514172-89514173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs367847835 | chr13:89514186-89514187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550373547 | chr13:89514222-89514223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370223487 | chr13:89514224-89514225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548367773 | chr13:89514238-89514239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576729708 | chr13:89514241-89514242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs80139679 | chr13:89514250-89514251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543876649 | chr13:89514305-89514306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192974314 | chr13:89514309-89514310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Osteosarcoma | 21215367 | CNVD |
Cancer | 20164920 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:89502600-89503400 | Enhancers | Fetal Heart | heart |
2 | chr13:89513800-89514800 | Enhancers | Fetal Brain Male | brain |
3 | chr13:89514000-89514600 | Enhancers | Fetal Brain Female | brain |
4 | chr13:89514600-89515600 | Weak transcription | Fetal Brain Female | brain |
5 | chr13:89514800-89516200 | Weak transcription | Fetal Brain Male | brain |
6 | chr13:89515600-89515800 | Enhancers | Fetal Brain Female | brain |
7 | chr13:89516200-89516400 | Enhancers | Fetal Brain Male | brain |
8 | chr13:89519000-89519400 | Enhancers | Dnd41 | blood |
9 | chr13:89519400-89519800 | Weak transcription | Dnd41 | blood |
10 | chr13:89519800-89521800 | Enhancers | Dnd41 | blood |
11 | chr13:89526000-89527000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr13:89538000-89538200 | Enhancers | Fetal Lung | lung |
13 | chr13:89538000-89538800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr13:89539200-89539800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr13:89539400-89539600 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
16 | chr13:89539400-89539800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr13:89539600-89539800 | Flanking Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
18 | chr13:89539600-89539800 | Enhancers | HepG2 | liver |
19 | chr13:89539800-89547600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
20 | chr13:89539800-89547600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr13:89539800-89548800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |